Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.241 USD | -0.82% | -4.63% | -24.43% |
Apr. 05 | North American Morning Briefing : Investors on -2- | DJ |
Apr. 04 | HC Wainwright Downgrades Asensus Surgical to Neutral From Buy, Adjusts PT to $0.35 From $2 | MT |
Financials (USD)
Sales 2024 * | 12.3M | Sales 2025 * | 22.21M | Capitalization | 65.55M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -55M | EV / Sales 2024 * | 5.33 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 * |
-1.3
x | P/E ratio 2025 * |
-1.66
x | Employees | 208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.96% |
Latest transcript on Asensus Surgical, Inc.
1 day | -0.82% | ||
1 week | -4.63% | ||
Current month | +4.78% | ||
3 months | -12.04% | ||
6 months | +10.65% | ||
Current year | -24.43% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Fernando
CEO | Chief Executive Officer | 52 | 15-07-31 |
Director of Finance/CFO | 57 | 20-08-23 | |
Motti Frimer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 04-12-31 | |
Kevin J. Hobert
BRD | Director/Board Member | 59 | 21-07-21 |
William Starling
FOU | Founder | 70 | 98-08-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.241 | -0.82% | 1,477,813 |
24-04-24 | 0.243 | -2.41% | 1,105,403 |
24-04-23 | 0.249 | -0.40% | 1,203,148 |
24-04-22 | 0.25 | 0.00% | 912,552 |
24-04-19 | 0.25 | -1.07% | 1,122,778 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.43% | 65.55M | |
-2.92% | 185B | |
-3.80% | 105B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+4.06% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- ASXC Stock